Center-Authored Papers

Browse: Authors | Keywords | All Center-Authored Publications
Filter by Division: Basic | Clinical | Human Biology | PHS | VIDD (2010-present) | VIDI (2008-2009)
Filter by Year: 2008 | 2009 | 2010 | 2011 | 2012 | 2013

Filters: Keyword is Public Health Sciences Division  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z   [Show ALL]
Z
Zuvich, RL, Armstrong LL, Bielinski SJ, Bradford Y, Carlson CS, Crawford DC, Crenshaw AT, de Andrade M, Doheny KF, Haines JL et al..  2011.  Pitfalls of merging GWAS data: lessons learned in the eMERGE network and quality control procedures to maintain high data quality.. Genetic epidemiology. 35(8):887-98. Abstract
Zschäbitz, S, Cheng T-YD, Neuhouser ML, Zheng Y, Ray RM, Miller JW, Song X, Maneval DR, Beresford SAA, Lane D et al..  2013.  B vitamin intakes and incidence of colorectal cancer: results from the Women's Health Initiative Observational Study cohort.. The American journal of clinical nutrition. 97(2):332-43. Abstract
Zonder, JA, Crowley J, Hussein MA, Bolejack V, Moore DF, Whittenberger BF, Abidi MH, Durie BGM, Barlogie B.  2010.  Lenalidomide and high-dose dexamethasone compared with dexamethasone as initial therapy for multiple myeloma: a randomized Southwest Oncology Group trial (S0232).. Blood. 116(26):5838-41. Abstract
Zolla-Pazner, S, Decamp AC, Cardozo T, Karasavvas N, Gottardo R, Williams C, Morris DE, Tomaras G, Rao M, Billings E et al..  2013.  Analysis of V2 antibody responses induced in vaccinees in the ALVAC/AIDSVAX HIV-1 vaccine efficacy trial.. PloS one. 8(1):e53629. Abstract
Zirpoli, GR, Brennan PM, Hong C-C, McCann SE, Ciupak G, Davis W, Unger JM, Thomas Budd G, Hershman DL, Moore HCF et al..  2013.  Supplement use during an intergroup clinical trial for breast cancer (S0221).. Breast cancer research and treatment. 137(3):903-13. Abstract
Zhuo, P, Goldberg M, Herman L, Lee B-S, Wang H, Brown RL, Foster CB, Peters U, Diamond AM.  2009.  Molecular consequences of genetic variations in the glutathione peroxidase 1 selenoenzyme.. Cancer research. 69(20):8183-90. Abstract
Zhu, J, Peng T, Johnston C, Phasouk K, Kask AS, Klock A, Jin L, Diem K, Koelle DM, Wald A et al..  2013.  Immune surveillance by CD8αα+ skin-resident T cells in human herpes virus infection.. Nature. 497(7450):494-7. Abstract
Zhu, Y, Stevens RG, Hoffman AE, Fitzgerald LM, Kwon EM, Ostrander EA, Davis S, Zheng T, Stanford JL.  2009.  Testing the circadian gene hypothesis in prostate cancer: a population-based case-control study.. Cancer research. 69(24):9315-22. Abstract
Zhu, CS, Pinsky PF, Cramer DW, Ransohoff DF, Hartge P, Pfeiffer RM, Urban ND, Mor G, Bast RC, Moore LE et al..  2011.  A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer.. Cancer prevention research (Philadelphia, Pa.). 4(3):375-83. Abstract
Zhu, L, Tong X, Zhao H, Sun J, Kumar Srivastava D, Leisenring W, Robison LL.  2012.  Statistical analysis of mixed recurrent event data with application to cancer survivor study.. Statistics in medicine. Abstract
Zhu, LJ, Gazin C, Lawson ND, Pagès H, Lin SM, Lapointe DS, Green MR.  2010.  ChIPpeakAnno: a Bioconductor package to annotate ChIP-seq and ChIP-chip data.. BMC bioinformatics. 11:237. Abstract
Zhou, QM, Zheng Y, Cai T.  2012.  Subgroup specific incremental value of new markers for risk prediction.. Lifetime data analysis. Abstract
Zhou, Y, Nair B, Shaughnessy JD, Cartron M-A, Haessler J, Anaissie E, van Rhee F, Crowley J, Barlogie B.  2009.  Cytogenetic abnormalities in multiple myeloma: poor prognosis linked to concomitant detection in random and focal lesion bone marrow samples and associated with high-risk gene expression profile.. British journal of haematology. 145(5):637-41. Abstract
Zhong, H, Prentice RL.  2010.  Correcting "winner's curse" in odds ratios from genomewide association findings for major complex human diseases.. Genetic epidemiology. 34(1):78-91. Abstract
Zheng, Y, Cai T, Stanford JL, Feng Z.  2010.  Semiparametric models of time-dependent predictive values of prognostic biomarkers.. Biometrics. 66(1):50-60. Abstract
Zheng, J, Gao X, Mato J, Beretta L, He F.  2008.  Report of the 9th HLPP Workshop October 2007, Seoul, Korea.. Proteomics. 8(17):3420-3. Abstract
Zheng, X, Levine D, Shen J, Gogarten SM, Laurie C, Weir BS.  2012.  A High-performance Computing Toolset for Relatedness and Principal Component Analysis of SNP Data.. Bioinformatics (Oxford, England). 28(24):3326-3328. Abstract
Zheng, Z, Margolis KL, Liu S, Tinker LF, Ye W.  2008.  Effects of estrogen with and without progestin and obesity on symptomatic gastroesophageal reflux.. Gastroenterology. 135(1):72-81. Abstract
Zheng, Y, Heagerty PJ, Hsu L, Newcomb PA.  2010.  On combining family-based and population-based case-control data in association studies.. Biometrics. 66(4):1024-33. Abstract
Zheng, Y, Cai T, Pepe MS, Levy WC.  2008.  Time-Dependent Predictive Values of Prognostic Biomarkers With Failure Time Outcome. Journal of the American Statistical Association. 103(481):362-368.
Zheng, Y, Cai T, Jin Y, Feng Z.  2012.  Evaluating Prognostic Accuracy of Biomarkers under Competing Risk.. Biometrics. 68(2):388-396. Abstract
Zheng, W, McLerran DF, Rolland B, Zhang X, Inoue M, Matsuo K, He J, Gupta PC, Ramadas K, Tsugane S et al..  2011.  Association between body-mass index and risk of death in more than 1 million Asians.. The New England journal of medicine. 364(8):719-29. Abstract
Zhao, LP, Huang X.  2013.  Recursive organizer (ROR): an analytic framework for sequence-based association analysis.. Human genetics. Abstract
Zhang, GL, Ansari HR, Bradley P, Cawley GC, Hertz T, Hu X, Jojic N, Kim Y, Kohlbacher O, Lund O et al..  2011.  Machine learning competition in immunology - Prediction of HLA class I binding peptides.. Journal of immunological methods. 374(1-2):1-4.
Zhang, Q, Menon R, Deutsch EW, Pitteri SJ, Faca VM, Wang H, Newcomb LF, DePinho RA, Bardeesy N, Dinulescu D et al..  2008.  A mouse plasma peptide atlas as a resource for disease proteomics.. Genome biology. 9(6):R93. Abstract